Alcohol Drinking, Apolipoprotein Polymorphisms and the Risk of Cardiovascular Diseases

(E-pub Ahead of Print)

Author(s): Flavio Maria Ceci, Mauro Ceccanti, Carla Petrella, Mario Vitali, Marisa Patrizia Messina, George N. Chaldakov, Antonio Greco, Massimo Ralli, Marco Lucarelli, Antonio Angeloni, Marco Fiore*, Giampiero Ferraguti

Journal Name: Current Neurovascular Research

Become EABM
Become Reviewer
Call for Editor


Lipoprotein disorders are a major risk factor for atherosclerotic neuro-cardiovascular disease (ACVD) and are heavily influenced by lifestyle, including alcohol drinking. Moderate drinkers have a lower ACVD risk than abstainers due to their higher levels of high-density lipoprotein (HDL) cholesterol, an important protective factor against ACVD. On the contrary, heavy drinking increases ACVD risk. According to an extensive literature body, ethanol intoxication modifies lipid serum profile and induces endothelial dysfunction. Single nucleotide polymorphisms may influence the relationship between alcohol drinking, HDL cholesterol level, and atherosclerotic risk. The risk of ACVD in heavy drinkers seems enhanced in patients with apolipoprotein E4 allele, interleukin- 6-174 polymorphism, and cholesteryl ester transfer protein TaqIB polymorphism. Apolipoprotein E4 is a known risk factor for ACVD, while apolipoprotein E2 has mixed effects. Therefore, even if a “protective role” may be attributed to moderate drinking, this effect cannot be extended to everyone.

Keywords: Alcoholism, genetic polymorphism, atherosclerotic cardiovascular disease, apolipoprotein E, adiponectin.

Rights & PermissionsPrintExport Cite as

Article Details

(E-pub Ahead of Print)
DOI: 10.2174/1567202618666210406123503
Price: $95

Article Metrics

PDF: 40